久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/03/26 | 4,165 | 4,167 | 4,121 | 4,150 | +25 | +0.6% | 90,200 |
| 2025/03/25 | 4,122 | 4,145 | 4,099 | 4,125 | ±0 | ±0% | 74,700 |
| 2025/03/24 | 4,120 | 4,141 | 4,085 | 4,125 | +5 | +0.1% | 114,600 |
| 2025/03/21 | 4,100 | 4,125 | 4,070 | 4,120 | +20 | +0.5% | 173,600 |
| 2025/03/19 | 4,077 | 4,127 | 4,077 | 4,100 | +4 | +0.1% | 116,200 |
| 2025/03/18 | 4,100 | 4,111 | 4,050 | 4,096 | -1 | ±0% | 160,400 |
| 2025/03/17 | 4,062 | 4,102 | 4,035 | 4,097 | +21 | +0.5% | 164,700 |
| 2025/03/14 | 4,067 | 4,118 | 4,062 | 4,076 | -3 | -0.1% | 170,500 |
| 2025/03/13 | 4,000 | 4,093 | 3,986 | 4,079 | +76 | +1.9% | 146,400 |
| 2025/03/12 | 4,028 | 4,054 | 3,987 | 4,003 | -77 | -1.9% | 247,700 |
| 2025/03/11 | 4,114 | 4,165 | 4,066 | 4,080 | -31 | -0.8% | 215,700 |
| 2025/03/10 | 4,112 | 4,139 | 4,079 | 4,111 | +13 | +0.3% | 193,100 |
| 2025/03/07 | 4,070 | 4,098 | 4,021 | 4,098 | -12 | -0.3% | 112,400 |
| 2025/03/06 | 4,116 | 4,169 | 4,101 | 4,110 | -46 | -1.1% | 102,800 |
| 2025/03/05 | 4,153 | 4,189 | 4,125 | 4,156 | -17 | -0.4% | 149,700 |
| 2025/03/04 | 4,205 | 4,250 | 4,171 | 4,173 | -32 | -0.8% | 93,300 |
| 2025/03/03 | 4,212 | 4,239 | 4,180 | 4,205 | -19 | -0.4% | 134,100 |
| 2025/02/28 | 4,269 | 4,282 | 4,211 | 4,224 | -42 | -1% | 185,100 |
| 2025/02/27 | 4,265 | 4,290 | 4,234 | 4,266 | -74 | -1.7% | 159,700 |
| 2025/02/26 | 4,376 | 4,380 | 4,315 | 4,340 | -36 | -0.8% | 150,400 |
| 2025/02/25 | 4,272 | 4,380 | 4,272 | 4,376 | +92 | +2.1% | 126,600 |
| 2025/02/21 | 4,220 | 4,321 | 4,204 | 4,284 | +47 | +1.1% | 153,600 |
| 2025/02/20 | 4,290 | 4,300 | 4,223 | 4,237 | -72 | -1.7% | 113,400 |
| 2025/02/19 | 4,316 | 4,376 | 4,292 | 4,309 | -24 | -0.6% | 104,200 |
| 2025/02/18 | 4,320 | 4,349 | 4,278 | 4,333 | +3 | +0.1% | 113,400 |
| 2025/02/17 | 4,301 | 4,367 | 4,295 | 4,330 | ±0 | ±0% | 116,300 |
| 2025/02/14 | 4,305 | 4,360 | 4,273 | 4,330 | +67 | +1.6% | 138,500 |
| 2025/02/13 | 4,292 | 4,298 | 4,260 | 4,263 | +8 | +0.2% | 91,100 |
| 2025/02/12 | 4,226 | 4,284 | 4,181 | 4,255 | +65 | +1.6% | 133,800 |
| 2025/02/10 | 4,230 | 4,238 | 4,178 | 4,190 | -40 | -0.9% | 80,000 |
| 2025/02/07 | 4,301 | 4,313 | 4,227 | 4,230 | -83 | -1.9% | 75,200 |
| 2025/02/06 | 4,316 | 4,338 | 4,275 | 4,313 | +6 | +0.1% | 81,400 |
| 2025/02/05 | 4,279 | 4,321 | 4,260 | 4,307 | +7 | +0.2% | 101,000 |
| 2025/02/04 | 4,413 | 4,428 | 4,297 | 4,300 | -84 | -1.9% | 119,300 |
| 2025/02/03 | 4,427 | 4,427 | 4,340 | 4,384 | -71 | -1.6% | 177,600 |
| 2025/01/31 | 4,492 | 4,502 | 4,450 | 4,455 | -49 | -1.1% | 120,300 |
| 2025/01/30 | 4,526 | 4,551 | 4,496 | 4,504 | -47 | -1% | 97,000 |
| 2025/01/29 | 4,564 | 4,585 | 4,528 | 4,551 | -13 | -0.3% | 120,800 |
| 2025/01/28 | 4,592 | 4,617 | 4,564 | 4,564 | -2 | ±0% | 93,600 |
| 2025/01/27 | 4,670 | 4,675 | 4,566 | 4,566 | -76 | -1.6% | 105,400 |
| 2025/01/24 | 4,652 | 4,678 | 4,629 | 4,642 | +2 | ±0% | 96,400 |
| 2025/01/23 | 4,618 | 4,663 | 4,605 | 4,640 | +22 | +0.5% | 96,400 |
| 2025/01/22 | 4,615 | 4,642 | 4,603 | 4,618 | +24 | +0.5% | 119,300 |
| 2025/01/21 | 4,543 | 4,618 | 4,543 | 4,594 | +51 | +1.1% | 157,200 |
| 2025/01/20 | 4,570 | 4,600 | 4,530 | 4,543 | -52 | -1.1% | 139,200 |
| 2025/01/17 | 4,630 | 4,637 | 4,558 | 4,595 | -18 | -0.4% | 145,800 |
| 2025/01/16 | 4,632 | 4,647 | 4,601 | 4,613 | -19 | -0.4% | 157,300 |
| 2025/01/15 | 4,644 | 4,676 | 4,589 | 4,632 | +21 | +0.5% | 219,800 |
| 2025/01/14 | 4,680 | 4,735 | 4,568 | 4,611 | -45 | -1% | 552,700 |
| 2025/01/10 | 4,250 | 4,685 | 4,244 | 4,656 | +612 | +15.1% | 2,090,100 |
101～
150
件表示中 / 3766件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 427,900円 | +5.8% | +1.2% | 2.80% | 13.86倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 139,600円 | -11.0% | +206.6% | 0.00% | 13.87倍 | 3.28倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 157,800円 | -2.0% | -7.3% | 2.41% | 15.42倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 361,900円 | +3.8% | -19.9% | 3.76% | 11.76倍 | 0.90倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 323,600円 | +3.6% | -15.3% | 3.83% | 9.09倍 | 0.89倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
